HANDAYANI, F. et al. 2025. IMPACT OF THE COMBINATION OF DOXORUBICIN, CYCLOPHOSPHAMIDE, AND DOCETAXEL ON CA 15-3 BIOMARKER LEVELS IN BREAST CANCER PATIENTS: A COMPARATIVE STUDY BETWEEN DELAYED AND NON-DELAYED CHEMOTHERAPY. International Journal of Applied Pharmaceutics. 17, 1 (Feb. 2025), 82–88. DOI:https://doi.org/10.22159/ijap.2025.v17s1.12.